miR199A-3p increases the antitumor efficacy of palbociclib in preclinical models of hepatocarcinoma

Raffaella Liuni, Elisa Callegari (Co-author), Paola Guerriero (Co-author), Cristian Bassi (Co-author), Lucilla D`Abundo (Co-author), Antonio Frassoldati (Co-author), Edi Simoni (Co-author), Laura Astolfi (Co-author), Enrico Maria Silini (Co-author), Silvia Sabbioni (Co-author), Massimo Negrini (Co-author)

Institute of Pharmacology and Toxicology

Research output: Contribution to conference › Poster

1 unpublished Abstract

1 results

2023

miR199A-3p Increases the antitumor efficacy of palbociclib in preclinical models of hepatocarcinoma
Liuni, R., Callegari, E. (Co-author), Guerriero, P. (Co-author), Bassi, C. (Co-author), D`Abundo, L. (Co-author), Frassoldati, A. (Co-author), Simoni, E. (Co-author), Astolfi, L. (Co-author), Silini, E. M. (Co-author), Sabbioni, S. (Co-author) & Negrini, M. (Co-author), 2023.
Research output: Contribution to conference › unpublished Abstract

miR199A-3p increases the antitumor efficacy of palbociclib in preclinical models of hepatocarcinoma

Research output

Search results

miR199A-3p Increases the antitumor efficacy of palbociclib in preclinical models of hepatocarcinoma